Anxiety News and Research

Latest Anxiety News and Research

Factors that increase the possibility of having migraines

A migraine is the most common type of headache that propels patients to seek care from their doctors. Roughly 30 million Americans suffer from migraine headaches, with women affected almost three times more often than men, according to statistics from the National Headache Foundation in Chicago.

21 Mar 2012

Synthetic marijuana use among teenagers raises concerns

According to reports three U.S. teenagers ended up in the emergency department with altered mental states and seriously elevated heart rates after smoking synthetic marijuana.

20 Mar 2012

“Meth” babies more at risk of behavioral problems: Study

A new study shows methamphetamine's potential lasting behavioral effects on kids of mothers who used meth during pregnancy. The behavior differences — anxiety, depression, moodiness — weren't huge, but lead researcher Linda LaGasse called them “very worrisome.”

20 Mar 2012

Acelrx fourth quarter net loss increases to $6.4 million

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the fourth quarter and year ended December 31, 2011.

20 Mar 2012

Study identifies risk factors for postpartum depressive symptoms

Many Norwegian women postpone pregnancy until they have completed their education and are well established on their career path. This may make them more vulnerable to postpartum depression.

20 Mar 2012

New book on war trauma and its aftermath

A new book by a University of New Hampshire researcher and Vietnam-era disabled veteran sheds new light on the long-term psychological trauma experienced by the coalition force in recent wars in the Gulf and Balkans that, when left untreated, can have deadly consequences.

20 Mar 2012

Heptares exercises exclusive option to license new A2A antagonist for CNS disorders

Heptares Therapeutics, the leading GPCR drug discovery company, announces that an operating company of Shire PLC, the global specialty biopharmaceutical company, has exercised its exclusive option to license a novel adenosine A2A antagonist discovered by Heptares that is currently in preclinical development.

20 Mar 2012

First Edition: March 19, 2012

Today's headlines reflect the anticipation and anxiety that surrounds the Supreme Court's upcoming health law oral arguments.

19 Mar 2012

Paper describes results of BMT in models of Rett Syndrome

A paper published online today in Nature describes the results of using bone marrow transplant (BMT) to replace faulty immune system cells in models of Rett Syndrome. The procedure arrested many severe symptoms of the childhood disorder, including abnormal breathing and movement, and significantly extended the lifespan of Rett mouse models.

19 Mar 2012

Sexually rejected male fruit flies binge on alcohol more than sexually satisfied peers: Study

Male fruit flies whose sexual advances are rejected by females, turn to alcohol finds a new study. Scientists at the University of California, San Francisco discovered that rejected male flies have a tiny molecule in their brain that pushes them to drink far more than their sexually satisfied counterparts. The levels of the molecule, neuropeptide F, were higher in sexually satisfied males than in those who got no sex, leading scientists to speculate that their work could shed light on brain mechanisms behind human addiction. A similar human molecule - neuropeptide Y - may also link social triggers to behaviors such as heavy drinking and drug abuse, according to the study published in Science journal.

18 Mar 2012

HHS Secretary launches new educational initiative, MyCare

Health and Human Services (HHS) Secretary Kathleen Sebelius today unveiled "MyCare," a collection of online personal video and blog stories of Americans helped by the Affordable Care Act.

17 Mar 2012

Post-chemotherapy cognitive changes impact lives of Asian breast cancer patients

A recent study by National University of Singapore (NUS) researchers revealed that Asian breast cancer patients who had received or were undergoing chemotherapy treatment showed symptoms of "chemobrain", in which they encounter memory loss, difficulty in decision making and speech problems.

16 Mar 2012

Neuropeptide F in the fly's brain governs behavior linked with addiction

Sexually deprived male fruit flies exhibit a pattern of behavior that seems ripped from the pages of a sad-sack Raymond Carver story: when female fruit flies reject their sexual advances, the males are driven to excessive alcohol consumption, drinking far more than comparable, sexually satisfied male flies.

16 Mar 2012

Depression increases risk of death in PCI patients

Depression increases the risk of death in patients who have a coronary stent implanted. After seven years of follow up, depressed patients were 1.5 times more likely to have died than non-depressed patients. The findings were independent of age, gender, clinical characteristics, anxiety and the distressed (Type D) personality.

16 Mar 2012

Teva gets exclusive 180 days to market generic antidepressant and anti-anxiety pill Lexapro

Teva Pharmaceutical Industries Ltd. Has won U.S. approval to sell the first generic version of Lexapro for depression and anxiety. Teva has been granted a 180-day exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the Food and Drug Administration (FDA) said in a news release.

15 Mar 2012

Fear of flying can be cured independently of YOH or after 4 sessions of VRET

This randomized controlled trial shows that fear of flying can be cured independently of drug condition [yohimbine hydrochloride (a noradrenaline agonist) or placebo] after 4 sessions of virtual reality exposure therapy (VRET).

15 Mar 2012

Many women experience memory problems during menopause, confirms study

The difficulties that many women describe as memory problems when menopause approaches are real, according to a study published today in the journal Menopause, the journal of the North American Menopause Society.

15 Mar 2012

AT-1001 shows promise in treating drug addiction

In preclinical studies, researchers at SRI International and Astraea Therapeutics have recently evaluated the role of a new drug receptor target that shows promise for the treatment of drug addiction.

15 Mar 2012

Exercise training can reduce worry symptoms among GAD patients

This study demonstrates that exercise training, including resistance exercise training, is a feasible, low-risk treatment that can potentially reduce worry symptoms among generalized anxiety disorder (GAD) patients and may be an effective adjuvant, short-term treatment or augmentation for GAD.

15 Mar 2012

Teva commences commercial launch of Escitalopram Oxalate Tablets

Teva Pharmaceutical Industries Ltd. announced today that it has commenced commercial launch of Escitalopram Oxalate Tablets, the Company's generic version of Forest Laboratories' depression and generalized anxiety disorder treatment, Lexapro Tablets.

15 Mar 2012